Abbott recalls (Class 1) its HeartMate 3 LVAS after reviewing complaints that identified blood or air leakages.
Federal Register notice: FDA issues an order permanently debarring Gina Acosta from providing services in any capacity to a person that has an approve...
Federal Register notice: FDA posts a technical amendment to its animal drug regulations for labeling new animal drugs included on the agencys Index of...
FDA approves the Roche HPV self-collection solution that the company says can expand access and screening options to help eliminate cervical cancer.
FDA warns Omaha, NE-based Cohere Beauty about CGMP violations in its Health Specialty drug manufacturing facility in Santa Fe Springs, CA.
The CDER Drug Trials Snapshop Summary Report 2023 provides statistics on the 55 novel drugs the Center approved in 2023.
FDA grants Juno Therapeutics accelerated approval for its BLA for Breyanzi (lisocabtagene maraleucel), a CAR T cell therapy for adults with relapsed o...
Rep. Mark Green (R-TN) introduces the Vaccines in Trial and Liability Act of 2024 that would ensure Americans are protected from fraudulent vaccine tr...
